SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-23-000862
Filing Date
2023-12-27
Accepted
2023-12-27 17:12:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2971
  Complete submission text file 0001968582-23-000862.txt   4772
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 144 | Act: 33 | File No.: 001-36830 | Film No.: 231518708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN, SALISBURY WILTSHIRE X0 SP4 0JQ
Business Address
Crockett Thomas Andrew (Reporting) CIK: 0001690920 (see all company filings)

Type: 144